Solid Biosciences

-$0.95 (-21.40%) Today
+$0.03 (+0.86%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SLDB and other stocks, options, and ETFs commission-free!

About SLDB

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy (DMD). It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD.

CEO
Ilan Ganot
Employees
70
Headquarters
Cambridge, Massachusetts
Founded
2013

SLDB Key Statistics

Market Cap
401.41M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
824.87K
High Today
$4.40
Low Today
$3.37
Open Price
$4.33
Volume
4.53M
52 Week High
$11.58
52 Week Low
$1.93

SLDB Earnings

-$0.67
-$0.45
-$0.22
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours

You May Also Like

SCHD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure